Biotech Co.* (Country; Symbol) |
Pharma Co. (Country) |
Product |
Terms/Details (Date) |
|
| |||
Advanced Plant Pharmaceuticals Inc. (OTC BB:APPI) |
Union Bless Ltd. (Hong Kong) |
Sinusol |
Distribution agreement for Union Bless to market and sell Advanced Plant's homeopathic allergy and sinus spray, Sinusol (8/19) |
|
|||
AlphaRx Inc. (OTC BB: ALRX) |
Industria Farmaceutica Andromaco SA de C.V. (Mexico) |
Indoflex |
Industria will manufacture, sell, market and distribute Indoflex throughout Mexico (9/4) |
|
|||
Bioenvision Inc. (AMEX:BIV) |
Stegram Pharmaceuticals Ltd. (UK) |
Modrenal |
Bioenvision obtained UK marketing rights to Modrenal to treat breast cancer (8/20) |
|
|||
CytoGenix Inc. (OTC BB: CYGX) |
Phanuel Pursuits LLC (British Virgin Islands) |
CytoGenix's anti-herpes topical cream |
Phanuel gained an exclusive license for the manufacture and distribution of CytoGenix's anti-herpes topical cream in the People's Republic of China (8/26) |
|
|||
Cytos Biotechnology AG (Switzerland; SWX:CYTN) |
Novartis AG (Switzerland) |
Cytos' Immunodrugs |
Novartis took a commercial license for Cytos' Immunodrugs against Alzheimer's disease; the event triggers an up-front payment, annual license fees and a milestone payment to Cytos (9/10) |
|
|||
Depomed Inc. (AMEX:DMI) |
Elan Corp. plc (Ireland) |
Gabapentin GR, a formulation of the seizure and pain drug |
Depomed acquired all rights to the drug that uses its Gastric Retention delivery system, as Elan dropped out of their venture; Depomed would pay milestones and royalties if a product is commercialized (9/22) |
|
|||
Gilead Sciences Inc. (GILD) |
Japan Tobacco Inc. (Japan) |
Viread, Emtriva and a future co-formulation of the products |
Licensing agreement in which Japan Tobacco will commercialize products in Gilead's HIV portfolio in Japan; Gilead will receive an up-front fee and could receive additional payments for milestones achieved; Japan Tobacco also would pay royalties (7/31) |
|
|||
Labopharm Inc. (Canada; TSE:DDS) |
Esteve SA (Spain) |
A once-daily version of the analgesic tramadol |
Esteve will market the product in Spain and Portugal; Labopharm will receive payments for certain milestones through to regulatory approval, and will earn a share of revenue from product sales (8/5) |
|
|||
Labopharm Inc. (Canada; TSE:DDS) |
Gruppo Angelini (Italy) |
A once-daily version of the analgesic tramadol |
Gruppo Angelini gained the exclusive right to market and sell the product in Italy and its related territories; Labopharm will supply Gruppo Angelini with finished packaged product through its European subsidiary (7/29) |
|
|||
Osiris Therapeutics Inc.* |
JCR Pharmaceuticals Co. Ltd. (Japan) |
A universal, adult mesenchymal stem cell technology |
JCR gained exclusive Japanese rights to the technology for treating hematologic malignancies using hematopoietic stem cell transplants; Osiris received an up-front license fee and would receive milestone payments and royalties upon product launch (8/27) |
|
|||
Pozen Inc. (POZN) |
Xcel Pharmaceuticals Inc. |
MT 300 |
Xcel will commercialize MT 300 to treat migraines in the U.S.; Xcel is paying Pozen a $2M up-front fee and potential milestone payments of up to $8M due upon certain regulatory approvals and the achievement of a predetermined sales threshold; Xcel also would pay double-digit royalties (9/4) |
|
|||
Qiagen NV (the Netherlands; QGENF) |
Novartis AG (Switzerland) |
siRNA molecules |
Qiagen will supply a genome-wide siRNA library to Novartis; financial terms were not disclosed (8/4) |
|
|||
Unigene Laboratories Inc. (OTC BB:UGNE) |
Faran Laboratories SA (Greece) |
Nasal calcitonin |
Faran gained an exclusive license to sell the product in Greece, after it obtains European and pricing approvals; Unigene gets an up-front payment, potential milestones and a fixed fee for each unit received (9/23) |
|
|||
Notes: | |||
# The information in the chart does not cover agricultural agreements or those between biotech companies. | |||
* Private companies are indicated with an asterisk. | |||
Unless otherwise noted, stock symbols listed are on the Nasdaq market. | |||
AMEX = American Stock Exchange; OTC BB = Over-the-Counter Bulletin Board; SWX = Swiss Stock Exchange; TSE = Toronto Stock Exchange. | |||
